Clinical Trials at PeeTu

Kliiniset tutkimukset -avoinna = Open for inclusion
Kliiniset tutkimukset - ei uusia potilaita =  Closed for inclusion

Clinical Cancer Trials

Cancer type Name in English
Acute lymphoblastic leukemia (ALL)
 
Kliiniset tutkimukset -avoinna GRASPA - Lohi
NOR-GRASPALL 2016 - Single-Arm pharmacokinetic/ pharmacodynamic and Safety Study of eryaspase (GRASPA®) for Patients with Hypersensitivity to PEG-asparaginase, diagnosed with Acute Lymphoblastic Leukemia
Relapsed/Refractory ALL, AML Kliiniset tutkimukset -avoinna isatuximab  - Lohi
Isatuximab in Combination with Chemotherapy in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
ALL, relapsed Kliiniset tutkimukset -avoinna IntReALL SR 2010 - Lohi
A randomised phase III study conducted by the resistant disease committee og the international BFM study group
Acute lymphoblastic leukemia (ALL) Kliiniset tutkimukset -avoinna NOPHO ALL-2008 
SNP and maintenance - Lohi   
High Risk Neuroblastoma Kliiniset tutkimukset -avoinna High risk neuroblastoma study 1.8 of SIOP-Europe (SIOPEN)   - Lohi
Acute myeloid leukaemia (AML) Kliiniset tutkimukset -avoinna NOPHO-DBH-2012 - Arola
Research study for treatment of children and adolescent with acute myeloid leukaemia 0-18 years
Ewing sarcoma Kliiniset tutkimukset -avoinna Euro-Ewing2008   - Arola
Ewing 2008 Study in localized and disseminated Ewing sarcoma
Ewing sarcoma, relapsed Kliiniset tutkimukset -avoinna rEECur - Arola
International randomised controlled trial of Chemotherapy for the treatment of recurrent and primary refractory ewing sarcoma
Medulloblastoma

 
Kliiniset tutkimukset -avoinna PNET 5 MB - Arola
An international prospective study on clinically standard-risk medulloblastoma in children older than 3 to 5 years with low-risk biological profile(PNET 5 MB-LR) or average-risk bilogical profile (PNET 5 MB-SR)
Leukemia Kliiniset tutkimukset -avoinna Leukemia biology - Lohi
Study on the biology and genomics of acute leukemia in childhood
B-cell lymphoma and leukemia Kliiniset tutkimukset -avoinna B-NHL 2013 - Raittinen
Treatment protocol for mature agressive B-cell lymphoma and leukemia in children and adolescents
High and low grade Glioma (HGG) Kliiniset tutkimukset -avoinna Phase II open-label global study to evaluate the effect of dabrafenib in combination with trametinib in children and adolescent patients with BRAF V600 mutation positive Low Grade Glioma (LGG) or relapsed or refractory High Grade Glioma (HGG)
Non-Hodgin-lymphoma Kliiniset tutkimukset -avoinna CNS HNL Flow study - Raittinen
Relapsed Malignancies in Childhood Kliiniset tutkimukset -avoinna INFORM Registry - Lohi
Individualized Therapy for Relapsed Malignancies in Childhood

Other Trials

Oral mucositis Kliiniset tutkimukset -avoinna Caphosol - Lohi
Supersaturated Calcium Phospate oral rinse (Caphosol) for the prevention of oral mucositis in children undergoing chemotherapeutic treatments
Diabetes Kliiniset tutkimukset -avoinna LIRA 1 - Palmu
Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults: Double-blind, Parallel Group Randomized Controlled Trial
Diabetes Kliiniset tutkimukset -avoinna LIRA 2 - Keskinen
Incretin-based therapy in early diagnosed Type 1 diabetes (TRIAL 2)
Diabetes Kliiniset tutkimukset -avoinna LIRA 3 - Palmu
Incretin-based Therapy in Late Preclinical Type 1 Diabetes: Double-blind, Parallel Group Randomized Controlled Trial
Diabetes Kliiniset tutkimukset -avoinna Simponi - Palmu
A Phase 1b Study to Evaluate SIMPONI® (golimumab) Therapy in Children, Adolescents
and Young Adults with Pre-Symptomatic Type 1 Diabetes 
Diabetes Kliiniset tutkimukset -avoinna Tefa -Palmu
A randomized investigator-initiated study to determine the effect of gluten free diet on beta-cell function and glucose metabolism in subjects positive for one or several islet autoantibodies
Venous thromboembolism  Kliiniset tutkimukset -avoinna Dabigatran - Palmu
Open-label, randomized, parallel-group, active-controlled, multi-centre, non-inferiority study of dabigatran etexilate versus standard of care for vte treatment in children from birth to less than 18 years of age: The DIVERSITY study
Antidote to VTE drug Kliiniset tutkimukset -avoinna Idarucizumab - Palmu
Single dose, open label, uncontrolled, safety trial of intravenous administration of idarucizumab to pediatric patients enrolled from ongoing phase IIb/III clinical trials with dabigatran etexilate for the treatment and secondary prevention of venous thromboembolism.